Global COVID-19 Drug API Market Growth (Status and Outlook) 2023-2029

February 2023 | 86 pages | ID: GEF101C13BC1EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “COVID-19 Drug API Industry Forecast” looks at past sales and reviews total world COVID-19 Drug API sales in 2022, providing a comprehensive analysis by region and market sector of projected COVID-19 Drug API sales for 2023 through 2029. With COVID-19 Drug API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world COVID-19 Drug API industry.

This Insight Report provides a comprehensive analysis of the global COVID-19 Drug API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on COVID-19 Drug API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global COVID-19 Drug API market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for COVID-19 Drug API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global COVID-19 Drug API.

The global COVID-19 Drug API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for COVID-19 Drug API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for COVID-19 Drug API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for COVID-19 Drug API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key COVID-19 Drug API players cover Shanghai Zhongxi Sunve Pharma Co., Ltd., Cinkate, Fuan Pharmaceutical Group, Wuhan Wuyao Pharmaceutical Co., Ltd, Shenhua Pharmaceutical Co., Ltd and Chongqing Kangle Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of COVID-19 Drug API market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Hydroxychloroquine
• Chloroquine Phosphate
• Others

Segmentation by application

• Tablet
• Injection

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Shanghai Zhongxi Sunve Pharma Co., Ltd.
• Cinkate
• Fuan Pharmaceutical Group
• Wuhan Wuyao Pharmaceutical Co., Ltd
• Shenhua Pharmaceutical Co., Ltd
• Chongqing Kangle Pharmaceutical Co., Ltd.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global COVID-19 Drug API Market Size 2018-2029
  2.1.2 COVID-19 Drug API Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 COVID-19 Drug API Segment by Type
  2.2.1 Hydroxychloroquine
  2.2.2 Chloroquine Phosphate
  2.2.3 Others
2.3 COVID-19 Drug API Market Size by Type
  2.3.1 COVID-19 Drug API Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global COVID-19 Drug API Market Size Market Share by Type (2018-2023)
2.4 COVID-19 Drug API Segment by Application
  2.4.1 Tablet
  2.4.2 Injection
2.5 COVID-19 Drug API Market Size by Application
  2.5.1 COVID-19 Drug API Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global COVID-19 Drug API Market Size Market Share by Application (2018-2023)

3 COVID-19 DRUG API MARKET SIZE BY PLAYER

3.1 COVID-19 Drug API Market Size Market Share by Players
  3.1.1 Global COVID-19 Drug API Revenue by Players (2018-2023)
  3.1.2 Global COVID-19 Drug API Revenue Market Share by Players (2018-2023)
3.2 Global COVID-19 Drug API Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 COVID-19 DRUG API BY REGIONS

4.1 COVID-19 Drug API Market Size by Regions (2018-2023)
4.2 Americas COVID-19 Drug API Market Size Growth (2018-2023)
4.3 APAC COVID-19 Drug API Market Size Growth (2018-2023)
4.4 Europe COVID-19 Drug API Market Size Growth (2018-2023)
4.5 Middle East & Africa COVID-19 Drug API Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas COVID-19 Drug API Market Size by Country (2018-2023)
5.2 Americas COVID-19 Drug API Market Size by Type (2018-2023)
5.3 Americas COVID-19 Drug API Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC COVID-19 Drug API Market Size by Region (2018-2023)
6.2 APAC COVID-19 Drug API Market Size by Type (2018-2023)
6.3 APAC COVID-19 Drug API Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe COVID-19 Drug API by Country (2018-2023)
7.2 Europe COVID-19 Drug API Market Size by Type (2018-2023)
7.3 Europe COVID-19 Drug API Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa COVID-19 Drug API by Region (2018-2023)
8.2 Middle East & Africa COVID-19 Drug API Market Size by Type (2018-2023)
8.3 Middle East & Africa COVID-19 Drug API Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL COVID-19 DRUG API MARKET FORECAST

10.1 Global COVID-19 Drug API Forecast by Regions (2024-2029)
  10.1.1 Global COVID-19 Drug API Forecast by Regions (2024-2029)
  10.1.2 Americas COVID-19 Drug API Forecast
  10.1.3 APAC COVID-19 Drug API Forecast
  10.1.4 Europe COVID-19 Drug API Forecast
  10.1.5 Middle East & Africa COVID-19 Drug API Forecast
10.2 Americas COVID-19 Drug API Forecast by Country (2024-2029)
  10.2.1 United States COVID-19 Drug API Market Forecast
  10.2.2 Canada COVID-19 Drug API Market Forecast
  10.2.3 Mexico COVID-19 Drug API Market Forecast
  10.2.4 Brazil COVID-19 Drug API Market Forecast
10.3 APAC COVID-19 Drug API Forecast by Region (2024-2029)
  10.3.1 China COVID-19 Drug API Market Forecast
  10.3.2 Japan COVID-19 Drug API Market Forecast
  10.3.3 Korea COVID-19 Drug API Market Forecast
  10.3.4 Southeast Asia COVID-19 Drug API Market Forecast
  10.3.5 India COVID-19 Drug API Market Forecast
  10.3.6 Australia COVID-19 Drug API Market Forecast
10.4 Europe COVID-19 Drug API Forecast by Country (2024-2029)
  10.4.1 Germany COVID-19 Drug API Market Forecast
  10.4.2 France COVID-19 Drug API Market Forecast
  10.4.3 UK COVID-19 Drug API Market Forecast
  10.4.4 Italy COVID-19 Drug API Market Forecast
  10.4.5 Russia COVID-19 Drug API Market Forecast
10.5 Middle East & Africa COVID-19 Drug API Forecast by Region (2024-2029)
  10.5.1 Egypt COVID-19 Drug API Market Forecast
  10.5.2 South Africa COVID-19 Drug API Market Forecast
  10.5.3 Israel COVID-19 Drug API Market Forecast
  10.5.4 Turkey COVID-19 Drug API Market Forecast
  10.5.5 GCC Countries COVID-19 Drug API Market Forecast
10.6 Global COVID-19 Drug API Forecast by Type (2024-2029)
10.7 Global COVID-19 Drug API Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Shanghai Zhongxi Sunve Pharma Co., Ltd.
  11.1.1 Shanghai Zhongxi Sunve Pharma Co., Ltd. Company Information
  11.1.2 Shanghai Zhongxi Sunve Pharma Co., Ltd. COVID-19 Drug API Product Offered
  11.1.3 Shanghai Zhongxi Sunve Pharma Co., Ltd. COVID-19 Drug API Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Shanghai Zhongxi Sunve Pharma Co., Ltd. Main Business Overview
  11.1.5 Shanghai Zhongxi Sunve Pharma Co., Ltd. Latest Developments
11.2 Cinkate
  11.2.1 Cinkate Company Information
  11.2.2 Cinkate COVID-19 Drug API Product Offered
  11.2.3 Cinkate COVID-19 Drug API Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Cinkate Main Business Overview
  11.2.5 Cinkate Latest Developments
11.3 Fuan Pharmaceutical Group
  11.3.1 Fuan Pharmaceutical Group Company Information
  11.3.2 Fuan Pharmaceutical Group COVID-19 Drug API Product Offered
  11.3.3 Fuan Pharmaceutical Group COVID-19 Drug API Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Fuan Pharmaceutical Group Main Business Overview
  11.3.5 Fuan Pharmaceutical Group Latest Developments
11.4 Wuhan Wuyao Pharmaceutical Co., Ltd
  11.4.1 Wuhan Wuyao Pharmaceutical Co., Ltd Company Information
  11.4.2 Wuhan Wuyao Pharmaceutical Co., Ltd COVID-19 Drug API Product Offered
  11.4.3 Wuhan Wuyao Pharmaceutical Co., Ltd COVID-19 Drug API Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Wuhan Wuyao Pharmaceutical Co., Ltd Main Business Overview
  11.4.5 Wuhan Wuyao Pharmaceutical Co., Ltd Latest Developments
11.5 Shenhua Pharmaceutical Co., Ltd
  11.5.1 Shenhua Pharmaceutical Co., Ltd Company Information
  11.5.2 Shenhua Pharmaceutical Co., Ltd COVID-19 Drug API Product Offered
  11.5.3 Shenhua Pharmaceutical Co., Ltd COVID-19 Drug API Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Shenhua Pharmaceutical Co., Ltd Main Business Overview
  11.5.5 Shenhua Pharmaceutical Co., Ltd Latest Developments
11.6 Chongqing Kangle Pharmaceutical Co., Ltd.
  11.6.1 Chongqing Kangle Pharmaceutical Co., Ltd. Company Information
  11.6.2 Chongqing Kangle Pharmaceutical Co., Ltd. COVID-19 Drug API Product Offered
  11.6.3 Chongqing Kangle Pharmaceutical Co., Ltd. COVID-19 Drug API Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Chongqing Kangle Pharmaceutical Co., Ltd. Main Business Overview
  11.6.5 Chongqing Kangle Pharmaceutical Co., Ltd. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. COVID-19 Drug API Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Hydroxychloroquine
Table 3. Major Players of Chloroquine Phosphate
Table 4. Major Players of Others
Table 5. COVID-19 Drug API Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global COVID-19 Drug API Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global COVID-19 Drug API Market Size Market Share by Type (2018-2023)
Table 8. COVID-19 Drug API Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global COVID-19 Drug API Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global COVID-19 Drug API Market Size Market Share by Application (2018-2023)
Table 11. Global COVID-19 Drug API Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global COVID-19 Drug API Revenue Market Share by Player (2018-2023)
Table 13. COVID-19 Drug API Key Players Head office and Products Offered
Table 14. COVID-19 Drug API Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global COVID-19 Drug API Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global COVID-19 Drug API Market Size Market Share by Regions (2018-2023)
Table 19. Global COVID-19 Drug API Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global COVID-19 Drug API Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas COVID-19 Drug API Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas COVID-19 Drug API Market Size Market Share by Country (2018-2023)
Table 23. Americas COVID-19 Drug API Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas COVID-19 Drug API Market Size Market Share by Type (2018-2023)
Table 25. Americas COVID-19 Drug API Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas COVID-19 Drug API Market Size Market Share by Application (2018-2023)
Table 27. APAC COVID-19 Drug API Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC COVID-19 Drug API Market Size Market Share by Region (2018-2023)
Table 29. APAC COVID-19 Drug API Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC COVID-19 Drug API Market Size Market Share by Type (2018-2023)
Table 31. APAC COVID-19 Drug API Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC COVID-19 Drug API Market Size Market Share by Application (2018-2023)
Table 33. Europe COVID-19 Drug API Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe COVID-19 Drug API Market Size Market Share by Country (2018-2023)
Table 35. Europe COVID-19 Drug API Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe COVID-19 Drug API Market Size Market Share by Type (2018-2023)
Table 37. Europe COVID-19 Drug API Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe COVID-19 Drug API Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa COVID-19 Drug API Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa COVID-19 Drug API Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa COVID-19 Drug API Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa COVID-19 Drug API Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa COVID-19 Drug API Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa COVID-19 Drug API Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of COVID-19 Drug API
Table 46. Key Market Challenges & Risks of COVID-19 Drug API
Table 47. Key Industry Trends of COVID-19 Drug API
Table 48. Global COVID-19 Drug API Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global COVID-19 Drug API Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global COVID-19 Drug API Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global COVID-19 Drug API Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Shanghai Zhongxi Sunve Pharma Co., Ltd. Details, Company Type, COVID-19 Drug API Area Served and Its Competitors
Table 53. Shanghai Zhongxi Sunve Pharma Co., Ltd. COVID-19 Drug API Product Offered
Table 54. Shanghai Zhongxi Sunve Pharma Co., Ltd. COVID-19 Drug API Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Shanghai Zhongxi Sunve Pharma Co., Ltd. Main Business
Table 56. Shanghai Zhongxi Sunve Pharma Co., Ltd. Latest Developments
Table 57. Cinkate Details, Company Type, COVID-19 Drug API Area Served and Its Competitors
Table 58. Cinkate COVID-19 Drug API Product Offered
Table 59. Cinkate Main Business
Table 60. Cinkate COVID-19 Drug API Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Cinkate Latest Developments
Table 62. Fuan Pharmaceutical Group Details, Company Type, COVID-19 Drug API Area Served and Its Competitors
Table 63. Fuan Pharmaceutical Group COVID-19 Drug API Product Offered
Table 64. Fuan Pharmaceutical Group Main Business
Table 65. Fuan Pharmaceutical Group COVID-19 Drug API Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Fuan Pharmaceutical Group Latest Developments
Table 67. Wuhan Wuyao Pharmaceutical Co., Ltd Details, Company Type, COVID-19 Drug API Area Served and Its Competitors
Table 68. Wuhan Wuyao Pharmaceutical Co., Ltd COVID-19 Drug API Product Offered
Table 69. Wuhan Wuyao Pharmaceutical Co., Ltd Main Business
Table 70. Wuhan Wuyao Pharmaceutical Co., Ltd COVID-19 Drug API Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Wuhan Wuyao Pharmaceutical Co., Ltd Latest Developments
Table 72. Shenhua Pharmaceutical Co., Ltd Details, Company Type, COVID-19 Drug API Area Served and Its Competitors
Table 73. Shenhua Pharmaceutical Co., Ltd COVID-19 Drug API Product Offered
Table 74. Shenhua Pharmaceutical Co., Ltd Main Business
Table 75. Shenhua Pharmaceutical Co., Ltd COVID-19 Drug API Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Shenhua Pharmaceutical Co., Ltd Latest Developments
Table 77. Chongqing Kangle Pharmaceutical Co., Ltd. Details, Company Type, COVID-19 Drug API Area Served and Its Competitors
Table 78. Chongqing Kangle Pharmaceutical Co., Ltd. COVID-19 Drug API Product Offered
Table 79. Chongqing Kangle Pharmaceutical Co., Ltd. Main Business
Table 80. Chongqing Kangle Pharmaceutical Co., Ltd. COVID-19 Drug API Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Chongqing Kangle Pharmaceutical Co., Ltd. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. COVID-19 Drug API Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global COVID-19 Drug API Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. COVID-19 Drug API Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. COVID-19 Drug API Sales Market Share by Country/Region (2022)
Figure 8. COVID-19 Drug API Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global COVID-19 Drug API Market Size Market Share by Type in 2022
Figure 10. COVID-19 Drug API in Tablet
Figure 11. Global COVID-19 Drug API Market: Tablet (2018-2023) & ($ Millions)
Figure 12. COVID-19 Drug API in Injection
Figure 13. Global COVID-19 Drug API Market: Injection (2018-2023) & ($ Millions)
Figure 14. Global COVID-19 Drug API Market Size Market Share by Application in 2022
Figure 15. Global COVID-19 Drug API Revenue Market Share by Player in 2022
Figure 16. Global COVID-19 Drug API Market Size Market Share by Regions (2018-2023)
Figure 17. Americas COVID-19 Drug API Market Size 2018-2023 ($ Millions)
Figure 18. APAC COVID-19 Drug API Market Size 2018-2023 ($ Millions)
Figure 19. Europe COVID-19 Drug API Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa COVID-19 Drug API Market Size 2018-2023 ($ Millions)
Figure 21. Americas COVID-19 Drug API Value Market Share by Country in 2022
Figure 22. United States COVID-19 Drug API Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada COVID-19 Drug API Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico COVID-19 Drug API Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil COVID-19 Drug API Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC COVID-19 Drug API Market Size Market Share by Region in 2022
Figure 27. APAC COVID-19 Drug API Market Size Market Share by Type in 2022
Figure 28. APAC COVID-19 Drug API Market Size Market Share by Application in 2022
Figure 29. China COVID-19 Drug API Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan COVID-19 Drug API Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea COVID-19 Drug API Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia COVID-19 Drug API Market Size Growth 2018-2023 ($ Millions)
Figure 33. India COVID-19 Drug API Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia COVID-19 Drug API Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe COVID-19 Drug API Market Size Market Share by Country in 2022
Figure 36. Europe COVID-19 Drug API Market Size Market Share by Type (2018-2023)
Figure 37. Europe COVID-19 Drug API Market Size Market Share by Application (2018-2023)
Figure 38. Germany COVID-19 Drug API Market Size Growth 2018-2023 ($ Millions)
Figure 39. France COVID-19 Drug API Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK COVID-19 Drug API Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy COVID-19 Drug API Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia COVID-19 Drug API Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa COVID-19 Drug API Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa COVID-19 Drug API Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa COVID-19 Drug API Market Size Market Share by Application (2018-2023)
Figure 46. Egypt COVID-19 Drug API Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa COVID-19 Drug API Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel COVID-19 Drug API Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey COVID-19 Drug API Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country COVID-19 Drug API Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 52. APAC COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 53. Europe COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 55. United States COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 56. Canada COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 57. Mexico COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 58. Brazil COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 59. China COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 60. Japan COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 61. Korea COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 63. India COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 64. Australia COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 65. Germany COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 66. France COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 67. UK COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 68. Italy COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 69. Russia COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 70. Spain COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 71. Egypt COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 72. South Africa COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 73. Israel COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 74. Turkey COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries COVID-19 Drug API Market Size 2024-2029 ($ Millions)
Figure 76. Global COVID-19 Drug API Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global COVID-19 Drug API Market Size Market Share Forecast by Application (2024-2029)